$7.4 billion Purdue Pharma and Sackler opioid settlement

 

Bankruptcy judge approves $7.4 billion Purdue Pharma opioid settlement. The judge said he would sign off on the deal next week, which will allow the OxyContin-maker to exit bankruptcy and settle lawsuits over the opioid’s impact against the company and the Sackler family that owns it. The decision on the latest plan comes after the Supreme Court rejected an earlier version because it let the Sackler family entirely off the hook for future opioid-related claims, even though some plaintiffs had not agreed to the settlement. In the new version, the Sacklers will contribute up to $7 billion over 15 years, and creditors who do not consent to the deal can still sue in civil court.